EUCLISES PHARMACEUTICALS INC has a total of 25 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2013. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and Australia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are ZAKLADY FARM POLPHARMA SA, GLYTHERA LTD and LUNAN NEW TIME BIO TECH CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 7 | |
#2 | United States | 6 | |
#3 | Australia | 2 | |
#4 | Canada | 2 | |
#5 | China | 2 | |
#6 | EPO (European Patent Office) | 2 | |
#7 | Mexico | 2 | |
#8 | Israel | 1 | |
#9 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Heterocyclic compounds | |
#3 | Therapeutic chemical compounds | |
#4 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Martinez Eduardo J | 21 |
#2 | Talley John J | 21 |
#3 | Sandage Bobby W | 6 |
#4 | Jerome Kevin D | 6 |
#5 | Boehm Terri L | 4 |
#6 | John J Talley | 2 |
#7 | Eduardo J Martinez | 2 |
#8 | Grigoriadis | 1 |
#9 | Sandage Jr Bobby W | 1 |
#10 | Grigoriadis Dimitri E | 1 |
Publication | Filing date | Title |
---|---|---|
CN108779091A | The combination of chromene compounds and the second activating agent | |
AU2015206528A1 | NO-releasing nitrooxy-chromene conjugates | |
US2015197500A1 | No-releasing guanidine-chromene conjugates | |
WO2015109017A2 | Deuterated no-releasing nonoate(oxygen-bound)chromene conjugates | |
US2015197494A1 | No-releasing nitrooxy-methylene-linked-coxib conjugates | |
US2014018403A1 | No-releasing guanidine-coxib anti-cancer agents | |
US2014018544A1 | No-releasing nonoate(nitrogen-bound)sulfonamide-linked-coxib anti-cancer agents |